PARPi exert their antitumor effects by inhibiting PARP-mediated DNA repair pathways and potentially impairing complementary DNA damage response mechanisms, hence enhancing tumor sensitivity to both radiotherapy and chemotherapy (26). This evidence concerns the gene PARP1 and neoplasm.